What amount sold does Soricimed Biopharma Inc. report in Form D filings?

The latest linked filings report $2.9M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Soricimed Biopharma Inc.'s most recent SEC filing?

Soricimed Biopharma Inc.'s most recent Form D filing was on 2023-01-19.

How many investors does Soricimed Biopharma Inc. have?

The most recent Form D filing lists 45 investor(s).

What type of securities does Soricimed Biopharma Inc. offer?

Soricimed Biopharma Inc.'s SEC Form D filings indicate equity offerings.

Soricimed Biopharma Inc.

CIK: 0001532755·Biotechnology·MONCTON, A3·Corporation

Reported Sold

$2,884,233

Total Filings

Identified Offerings

Last Filed

Jan 19, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 19, 2023Form D/A — Amendment

Reported sold: $2,775,233 · Target: $3,732,179

Rule 506(c)·45 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 31, 2022Form D — New notice

Reported sold: $1,414,655 · Target: $3,929,597

Rule 506(c)·42 investors

Oct 18, 2011Form D — New notice

Reported sold: $109,000 · Target: $109,000

Section 4(a)(2)·2 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$2,884,233

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Paul Gunn

Related Person

Appears on 3 filings

Robert Bruce

Related Person

Appears on 2 filings

Susan Hicks

Related Person

Appears on 2 filings

Jack Stewart

Related Person

Appears on 2 filings

Marc Rubin

Related Person

Appears on 2 filings

Camille Belliveau

Related Person

Appears on 2 filings

Vaughn Embro-Pantelony

Related Person

Appears on 2 filings

Jack Stewart

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 19, 2023	Amendment	$3,732,179	$2,775,233	45
Jan 31, 2022	New	$3,929,597	$1,414,655	42
Oct 18, 2011	New	$109,000	$109,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Ausel, Inc.

Biotechnology

Offering target: $5,000,000

Filed Nov 4, 2026